1. Home
  2. BSX vs LEO Comparison

BSX vs LEO Comparison

Compare BSX & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • LEO
  • Stock Information
  • Founded
  • BSX 1979
  • LEO 1987
  • Country
  • BSX United States
  • LEO United States
  • Employees
  • BSX 53000
  • LEO N/A
  • Industry
  • BSX Medical/Dental Instruments
  • LEO Trusts Except Educational Religious and Charitable
  • Sector
  • BSX Health Care
  • LEO Finance
  • Exchange
  • BSX Nasdaq
  • LEO Nasdaq
  • Market Cap
  • BSX 138.5B
  • LEO N/A
  • IPO Year
  • BSX 1992
  • LEO N/A
  • Fundamental
  • Price
  • BSX $95.12
  • LEO $5.81
  • Analyst Decision
  • BSX Strong Buy
  • LEO
  • Analyst Count
  • BSX 23
  • LEO 0
  • Target Price
  • BSX $107.61
  • LEO N/A
  • AVG Volume (30 Days)
  • BSX 10.1M
  • LEO 200.2K
  • Earning Date
  • BSX 04-23-2025
  • LEO 01-01-0001
  • Dividend Yield
  • BSX N/A
  • LEO 4.01%
  • EPS Growth
  • BSX 16.82
  • LEO N/A
  • EPS
  • BSX 1.25
  • LEO 0.04
  • Revenue
  • BSX $16,747,000,000.00
  • LEO N/A
  • Revenue This Year
  • BSX $15.60
  • LEO N/A
  • Revenue Next Year
  • BSX $10.28
  • LEO N/A
  • P/E Ratio
  • BSX $76.10
  • LEO $152.00
  • Revenue Growth
  • BSX 17.61
  • LEO N/A
  • 52 Week Low
  • BSX $66.80
  • LEO $4.98
  • 52 Week High
  • BSX $107.17
  • LEO $6.50
  • Technical
  • Relative Strength Index (RSI)
  • BSX 45.80
  • LEO 36.81
  • Support Level
  • BSX $86.77
  • LEO $5.55
  • Resistance Level
  • BSX $96.69
  • LEO $6.11
  • Average True Range (ATR)
  • BSX 4.05
  • LEO 0.12
  • MACD
  • BSX -0.02
  • LEO -0.02
  • Stochastic Oscillator
  • BSX 59.74
  • LEO 38.81

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Share on Social Networks: